RESPONSE GENETICS, INC. & DELCATH SYSTEMS, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed four positions; three for gains and one for a loss.

ZOGENIX (4/20/12). Closed position 10/4/12 at $3.27 for a 70% GAIN.

FIVE STAR QUALITY CARE (5/5/12). Closed position 10/8/12 at $5.74 for a 60% GAIN.

VALUE VISION MEDIA (9/5/12). Closed position 10/10/12 at $2.78 for a 51% GAIN.

U.S. GEOTHERMAL (8/5/08). Closed position 10/8/12 at 32 cents for an 86% LOSS.

(more…)

ANTHERA PHARMACEUTICALS, INC. & ZYNGA, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed one position for a loss.

COMPLETE GENOMICS (2/20/12). Closed position 9/26/12 at $3.15 for a 22% LOSS.

We did not envision ending our drought of closing Current Positions with a loss, but we had to such it up as Complete Genomics was acquired by BGI-Shenzhen at $3.15 a share, which we think is a steal; and judging by the number of law suits being filed against the acquisition, we are not alone in our thinking.

(more…)

IMMUNOCELLULAR THERAPEUTICS, LTD. & HANSEN MEDICAL, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

The markets are still all about the world’s central bankers. They more they flood the financial system with new money the more the markets cheer, and, therein, is one of history’s all-time paradoxes. The reason for the constant flow of new liquidity is because the underpinnings of the globes economic structures are damaged and weak. Shouldn’t the markets be acting adversely to future fiascos? The rational answer is “yes”, but markets are seldom rational. They live for the here and now. Investors, namely fund managers and institutions, are able to borrow at minimal rates so as to buy more equities. Talk about Ponzi schemes! During the last few years, the main beneficiaries have been big and mid cap stocks. However, during recent months, some of the largesse has started trickling down to the small caps.

(more…)

VALUE VISION MEDIA, INC. & AXT, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

And so, again, the markets remain fixated on the Federal Reserve and monetary policy as Chairman Ben keeps alluding to the idea that the central bank could ease financial conditions even more, if that is still possible. The day this Newsletter is posted, August 31, the Chairman is to give his annual Jackson Hole address, which could set the markets’ path for September, and, perhaps, up until Election Day. The problem with all of this Fed easing is that it is having very little impact neither on Main Street nor on small stocks, which is our fixation. Any new Fed money is channeled into institutions and banks that shovel it into mutual funds, hedge funds, and ETFs, which in turn lap up big cap stocks and other such financial instruments. As we have said on countless occasions, this is no way to run a stock market, much less a country. Oh, and let’s not forget about Europe.

(more…)

MERU NETWORKS, INC. & SEMILEDS CORPORATION

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

As we said in the last Newsletter, this market has disregarded fundamentals and value, and is taking its marching orders from the world’s central bankers. In short, this is getting a lot scary. Regardless of how much money the bankers dole out, Spain, Greece, Ireland, Portugal, and Italy still need to do more budget magic, and, oh yes, pay back all of that borrowing at some point. And, oops, we almost forgot a country, the United States.

(more…)

NOVATEL WIRELESS, INC. & pSIVIDA CORPORATION

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

This is no way to run an economy and it is definitely no way to run a country. Worst yet, it is no way to run the markets, and, therein is the problem. Markets are not to be “run” or manipulated. They should be allowed to free range. However, every time the markets attempt to find their true values, which are probably lower, some central banker, or their spokesperson alludes to more quantitative easing. Of course, this occurs during major market sell offs and these pronouncements have been leading to sugar rushes, which have created artificially-priced stocks. Can anyone say with a straight face that any stock in the S&P 500 is priced at its fundamentals? We doubt it.

(more…)

OVERLAND STORAGE, INC. & AVIAT NETWORKS, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed one position, for a gain.

NAVIDEA BIOPHARMACEUTICALS (1/5/12). Closed position 7/3/12 at $4.28 for a 68% GAIN.

For most of June Navidea BioPharma made a nice run on several pieces of upbeat news and we happily took the gain.

And, once again, as we have been saying for the last several months, the markets have still been about Europe, and, again, we are on the verge of another downward spiral. Now, we also have the specter of a lousy earnings season staring us right in the face, along with election uncertainties. Oh sure, over the next month, or so, we may get a few slivers of “good news” that will spawn some feel-good rallies, but the immediate market landscape remains a little bleak. And, once again, our Current Portfolio has been feeling the brunt of this.

(more…)

METABOLIX, INC. & ATHERSYS, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed seven positions; four for gains and three for losses.

Nanosphere (1/20/12). Closed position 6/27/12 at $2.53 for a 58% GAIN.

CELSION (3/15/12). Closed position 6/26/12 at $3.24 for a 62% GAIN.

ANTHERA PHARMACEUTICALS (6/5/12). Closed position 6/26/12 at $3.16 for a 60% GAIN.

ANTARES PHRMA (8/5/11). Closed position 6/20/12 at $3.72 for a 60% GAIN.

NETWORK ENGINES (2/5/11). Closed position 6/20/12 at $1.45 for a 21% LOSS.

(acquired by Unicom Systems)

SATCON TECHNOLOGY (8/5/11). Closed position 6/25/12 at 25 cents for an 87% LOSS.

LRAD Corp. (10/5/07). Closed position 6/27/12 at $1.21 for a 68% LOSS.

(more…)

VERMILLION, INC. & RARE ELEMENT RESOURCES, LTD.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

As we have been saying for the last several months that, with few exceptions, the markets are all about Europe all of the time. Yes, the markets had somewhat of a reprieve over the last few weeks, which may have been a dead-cat bounce. The day we publish this Newsletter, June 18, Greece’s election results will be known, and two days later the June Fed meeting will be over. We haven’t a clue as to how the markets will respond to either of these events, short-term. However, we do know one thing and that is current global monetary policies are not really helping the man or the woman on the street, be they in the U.S., Greece, Spain, or Italy.

(more…)

ANTHERA PHARMACEUTICALS, INC. & AVANIR PHARMACEUTICALS, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

The day this Newsletter is posted, June 1, is the same day that the May jobs report is released, so, for one day, the markets will probably divert their attention from Europe. Regardless of what the jobs number is, the market focus for the foreseeable future will be on Europe. The governments over there are doing the same thing that the Fed and the Treasury did in the U.S. and that is to screw Main Street and save the banks. That strategy really isn’t working too well here, and, given the high unemployment in Greece and Spain, it is not working too well in Europe. Oh sure, our markets will have days when the blinders are kept on and the markets may go on periodic feel-good mini-runs, but global realties will be serving up cold showers for quite some time. Unless the Fed announces the start of QE3, and that changes the landscape, and, BTW, this is becoming more and more of a possibility.

(more…)